Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Recurrent Urinary Tract Infection

In brief

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

Key facts

Study ID

NCT06050148

Run by

Helsinki University Central Hospital

People needed

100

Starts

2023-08-01

Expected to finish

2029-12-31

Last updated by the study team

2023-09-22

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female subjects aged ≥18
• History of recurrent UTI: at least two episodes of UTI over the past 6 months or at least three episodes over the past year, most recent episode within the past three months
• Written informed consent

You may not qualify if…

• Suspected non-compliance
• Diagnosis of a gastrointestinal disease
• Pregnancy
• Immunosuppression
• Any kind of permanent urinary catheter or intermittent urinary catheterization
• Any other criteria which, in the investigator's opinion, would compromise the ability of the subject to participate in the study, the subject's well-being, or the outcome of the study

Where it is running

• Meilahti Vaccine Research Center, Helsinki University Central Hospital — Helsinki, Finland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.